A left atrial appendage thrombus that developed during prophylactic low‐dose dabigatran treatment resolved after switching to apixaban
Author(s) -
Koyama Taku,
Otsuka Yoritaka,
Kawahara Masaaki,
Imoto Yuki,
Nakamura Keita,
Kodama Sunao,
Noguchi Hiroo
Publication year - 2017
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.933
Subject(s) - medicine , apixaban , dabigatran , thrombus , appendage , cardiology , atrial appendage , atrial fibrillation , warfarin , rivaroxaban , anatomy , sinus rhythm
Key Clinical Message We describe a case of atrial fibrillation in which an intracardiac thrombus that could not be prevented with “low‐dose” dabigatran treatment was resolved by switching to apixaban treatment. Thrombolysis using direct oral anticoagulants ( DOAC s) could be a therapeutic option for patients with intracardiac thrombi, although the efficacies of different DOAC s seem to differ and need further examination.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom